Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Estimation of regional soil organic carbon stocks merging classified land-use information with detailed soil data.

Illiger P, Schmidt G, Walde I, Hese S, Kudrjavzev AE, Kurepina N, Mizgirev A, Stephan E, Bondarovich A, Frühauf M.

Sci Total Environ. 2019 Aug 3;695:133755. doi: 10.1016/j.scitotenv.2019.133755. [Epub ahead of print]

PMID:
31421328
2.

Publisher Correction: Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.

Howard NC, Marin ND, Ahmed M, Rosa BA, Martin J, Bambouskova M, Sergushichev A, Loginicheva E, Kurepina N, Rangel-Moreno J, Chen L, Kreiswirth BN, Klein RS, Balada-Llasat JM, Torrelles JB, Amarasinghe GK, Mitreva M, Artyomov MN, Hsu FF, Mathema B, Khader SA.

Nat Microbiol. 2018 Nov;3(11):1327. doi: 10.1038/s41564-018-0281-9.

PMID:
30327492
3.

Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.

Howard NC, Marin ND, Ahmed M, Rosa BA, Martin J, Bambouskova M, Sergushichev A, Loginicheva E, Kurepina N, Rangel-Moreno J, Chen L, Kreiswirth BN, Klein RS, Balada-Llasat JM, Torrelles JB, Amarasinghe GK, Mitreva M, Artyomov MN, Hsu FF, Mathema B, Khader SA.

Nat Microbiol. 2018 Oct;3(10):1099-1108. doi: 10.1038/s41564-018-0245-0. Epub 2018 Sep 17. Erratum in: Nat Microbiol. 2018 Nov;3(11):1327.

4.

Structure-Based Design of MptpB Inhibitors That Reduce Multidrug-Resistant Mycobacterium tuberculosis Survival and Infection Burden in Vivo.

Vickers CF, Silva APG, Chakraborty A, Fernandez P, Kurepina N, Saville C, Naranjo Y, Pons M, Schnettger LS, Gutierrez MG, Park S, Kreiswith BN, Perlin DS, Thomas EJ, Cavet JS, Tabernero L.

J Med Chem. 2018 Sep 27;61(18):8337-8352. doi: 10.1021/acs.jmedchem.8b00832. Epub 2018 Sep 10.

5.

Towards better prediction of Mycobacterium tuberculosis lineages from MIRU-VNTR data.

Thain N, Le C, Crossa A, Ahuja SD, Meissner JS, Mathema B, Kreiswirth B, Kurepina N, Cohen T, Chindelevitch L.

Infect Genet Evol. 2019 Aug;72:59-66. doi: 10.1016/j.meegid.2018.06.029. Epub 2018 Jun 28.

6.

Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.

Cheng CY, Gutierrez NM, Marzuki MB, Lu X, Foreman TW, Paleja B, Lee B, Balachander A, Chen J, Tsenova L, Kurepina N, Teng KWW, West K, Mehra S, Zolezzi F, Poidinger M, Kreiswirth B, Kaushal D, Kornfeld H, Newell EW, Singhal A.

Sci Immunol. 2017 Mar;2(9). pii: eaaj1789. doi: 10.1126/sciimmunol.aaj1789. Epub 2017 Mar 24.

7.

Genotypic characterisation of Mycobacterium tuberculosis isolates from tuberculous meningitis patients at a tertiary neurocare centre in Southern India.

Chandramuki A, Khanna N, Shashkina E, Kurepina N, Mathema B, Kreiswirth BN, Venkataswamy MM.

Indian J Med Microbiol. 2017 Apr-Jun;35(2):211-215. doi: 10.4103/ijmm.IJMM_16_166.

8.

Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis.

Singh SB, Xu L, Meinke PT, Kurepina N, Kreiswirth BN, Olsen DB, Young K.

J Antibiot (Tokyo). 2017 May;70(5):671-674. doi: 10.1038/ja.2016.165. Epub 2017 Jan 18.

PMID:
28096545
9.

Spoligotyping of Mycobacterium tuberculosis Complex Isolates by Use of Ligation-Based Amplification and Melting Curve Analysis.

Zeng X, Li H, Zheng R, Kurepina N, Kreiswirth BN, Zhao X, Xu Y, Li Q.

J Clin Microbiol. 2016 Sep;54(9):2384-7. doi: 10.1128/JCM.00857-16. Epub 2016 Jun 22.

10.

MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.

Stinson K, Kurepina N, Venter A, Fujiwara M, Kawasaki M, Timm J, Shashkina E, Kreiswirth BN, Liu Y, Matsumoto M, Geiter L.

Antimicrob Agents Chemother. 2016 May 23;60(6):3316-22. doi: 10.1128/AAC.03014-15. Print 2016 Jun.

11.

Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.

Farhat MR, Sultana R, Iartchouk O, Bozeman S, Galagan J, Sisk P, Stolte C, Nebenzahl-Guimaraes H, Jacobson K, Sloutsky A, Kaur D, Posey J, Kreiswirth BN, Kurepina N, Rigouts L, Streicher EM, Victor TC, Warren RM, van Soolingen D, Murray M.

Am J Respir Crit Care Med. 2016 Sep 1;194(5):621-30. doi: 10.1164/rccm.201510-2091OC.

12.

Metformin as adjunct antituberculosis therapy.

Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, Tsenova L, Kurepina N, Chen J, Zolezzi F, Kreiswirth B, Poidinger M, Chee C, Kaplan G, Wang YT, De Libero G.

Sci Transl Med. 2014 Nov 19;6(263):263ra159. doi: 10.1126/scitranslmed.3009885.

13.

Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community.

Middelkoop K, Bekker LG, Mathema B, Myer L, Shashkina E, Whitelaw A, Kurepina N, Kaplan G, Kreiswirth B, Wood R.

Int J Epidemiol. 2014 Aug;43(4):1114-22. doi: 10.1093/ije/dyu044. Epub 2014 Mar 7.

14.

Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.

Mustaev A, Malik M, Zhao X, Kurepina N, Luan G, Oppegard LM, Hiasa H, Marks KR, Kerns RJ, Berger JM, Drlica K.

J Biol Chem. 2014 May 2;289(18):12300-12. doi: 10.1074/jbc.M113.529164. Epub 2014 Feb 4.

15.

Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis.

Farhat MR, Shapiro BJ, Kieser KJ, Sultana R, Jacobson KR, Victor TC, Warren RM, Streicher EM, Calver A, Sloutsky A, Kaur D, Posey JE, Plikaytis B, Oggioni MR, Gardy JL, Johnston JC, Rodrigues M, Tang PK, Kato-Maeda M, Borowsky ML, Muddukrishna B, Kreiswirth BN, Kurepina N, Galagan J, Gagneux S, Birren B, Rubin EJ, Lander ES, Sabeti PC, Murray M.

Nat Genet. 2013 Oct;45(10):1183-9. doi: 10.1038/ng.2747. Epub 2013 Sep 1.

16.

Growth-inhibitory activity of natural and synthetic isothiocyanates against representative human microbial pathogens.

Kurepina N, Kreiswirth BN, Mustaev A.

J Appl Microbiol. 2013 Oct;115(4):943-54. doi: 10.1111/jam.12288. Epub 2013 Jul 19.

17.

[Toxocariasis in the Republic of Altai. Geoinformation mapping simulation].

Pautova EA, Kurepina NIu, Dovgalev AS.

Med Parazitol (Mosk). 2012 Oct-Dec;(4):11-4. Russian.

PMID:
23437715
18.

Inferred spoligoforest topology unravels spatially bimodal distribution of mutations in the DR region.

Ozcaglar C, Shabbeer A, Kurepina N, Rastogi N, Yener B, Bennett KP.

IEEE Trans Nanobioscience. 2012 Sep;11(3):191-202. doi: 10.1109/TNB.2012.2213265.

PMID:
22987125
19.

Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease.

Adams LV, Kreiswirth BN, Arbeit RD, Soini H, Mtei L, Matee M, Bakari M, Lahey T, Wieland-Alter W, Shashkina E, Kurepina N, Driscoll JR, Pallangyo K, Horsburgh CR, von Reyn CF.

J Clin Microbiol. 2012 Aug;50(8):2645-50. doi: 10.1128/JCM.00624-12. Epub 2012 May 30.

20.

Induction of mycobacterial resistance to quinolone class antimicrobials.

Malik M, Chavda K, Zhao X, Shah N, Hussain S, Kurepina N, Kreiswirth BN, Kerns RJ, Drlica K.

Antimicrob Agents Chemother. 2012 Jul;56(7):3879-87. doi: 10.1128/AAC.00474-12. Epub 2012 May 7.

21.

Data-driven insights into deletions of Mycobacterium tuberculosis complex chromosomal DR region using spoligoforests.

Ozcaglar C, Shabbeer A, Kurepina N, Yener B, Bennett KP.

Proceedings (IEEE Int Conf Bioinformatics Biomed). 2011:75-82.

22.

Epidemiologic consequences of microvariation in Mycobacterium tuberculosis.

Mathema B, Kurepina N, Yang G, Shashkina E, Manca C, Mehaffy C, Bielefeldt-Ohmann H, Ahuja S, Fallows DA, Izzo A, Bifani P, Dobos K, Kaplan G, Kreiswirth BN.

J Infect Dis. 2012 Mar 15;205(6):964-74. doi: 10.1093/infdis/jir876. Epub 2012 Feb 7.

23.

Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio) Mycobacterium tuberculosis sublineage.

Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LC, Chiu Y, Li J, Ahuja S, Driscoll J, Kreiswirth BN, Ho JL.

Infect Genet Evol. 2012 Jun;12(4):664-70. doi: 10.1016/j.meegid.2011.07.018. Epub 2011 Aug 2.

24.

Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.

Perri BR, Proops D, Moonan PK, Munsiff SS, Kreiswirth BN, Kurepina N, Goranson C, Ahuja SD.

Emerg Infect Dis. 2011 Mar;17(3):372-378. doi: 10.3201/eid1703.101002.

25.

Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry.

Massire C, Ivy CA, Lovari R, Kurepina N, Li H, Blyn LB, Hofstadler SA, Khechinashvili G, Stratton CW, Sampath R, Tang YW, Ecker DJ, Kreiswirth BN.

J Clin Microbiol. 2011 Mar;49(3):908-17. doi: 10.1128/JCM.01578-10. Epub 2010 Dec 29.

26.

Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay.

Chakravorty S, Aladegbami B, Thoms K, Lee JS, Lee EG, Rajan V, Cho EJ, Kim H, Kwak H, Kurepina N, Cho SN, Kreiswirth B, Via LE, Barry CE 3rd, Alland D.

J Clin Microbiol. 2011 Mar;49(3):932-40. doi: 10.1128/JCM.02271-10. Epub 2010 Dec 29.

27.

Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence.

Middelkoop K, Bekker LG, Mathema B, Shashkina E, Kurepina N, Whitelaw A, Fallows D, Morrow C, Kreiswirth B, Kaplan G, Wood R.

J Infect Dis. 2009 Oct 15;200(8):1207-11. doi: 10.1086/605930.

28.

Comparative in vitro activity of oritavancin against recent, genetically diverse, community-associated meticillin-resistant Staphylococcus aureus (MRSA) isolates.

Arhin FF, Kurepina N, Sarmiento I, Parr TR Jr, Moeck G, Kreiswirth B.

Int J Antimicrob Agents. 2010 Jan;35(1):93-4. doi: 10.1016/j.ijantimicag.2009.07.012. Epub 2009 Sep 9. No abstract available.

PMID:
19744836
29.

Genotyping of Mycobacterium tuberculosis clinical isolates using IS6110-based restriction fragment length polymorphism analysis.

Bifani P, Kurepina N, Mathema B, Wang XM, Kreiswirth B.

Methods Mol Biol. 2009;551:173-88. doi: 10.1007/978-1-60327-999-4_14.

PMID:
19521875
30.

Mycobacterium tuberculosis in Ontario, Canada: Insights from IS6110 restriction fragment length polymorphism and mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping.

Alexander DC, Guthrie JL, Pyskir D, Maki A, Kurepina N, Kreiswirth BN, Chedore P, Drews SJ, Jamieson F.

J Clin Microbiol. 2009 Aug;47(8):2651-4. doi: 10.1128/JCM.01946-08. Epub 2009 Jun 3.

31.

Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.

Mathys V, Wintjens R, Lefevre P, Bertout J, Singhal A, Kiass M, Kurepina N, Wang XM, Mathema B, Baulard A, Kreiswirth BN, Bifani P.

Antimicrob Agents Chemother. 2009 May;53(5):2100-9. doi: 10.1128/AAC.01197-08. Epub 2009 Feb 23.

32.

Lessons from molecular epidemiology and comparative genomics.

Mathema B, Kurepina N, Fallows D, Kreiswirth BN.

Semin Respir Crit Care Med. 2008 Oct;29(5):467-80. doi: 10.1055/s-0028-1085699. Epub 2008 Sep 22. Review.

PMID:
18810681
33.

The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population.

Bifani P, Mathema B, Kurepina N, Shashkina E, Bertout J, Blanchis AS, Moghazeh S, Driscoll J, Gicquel B, Frothingham R, Kreiswirth BN.

J Infect Dis. 2008 Jul 1;198(1):90-4. doi: 10.1086/588822.

PMID:
18498237
34.

The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence.

Sinsimer D, Huet G, Manca C, Tsenova L, Koo MS, Kurepina N, Kana B, Mathema B, Marras SA, Kreiswirth BN, Guilhot C, Kaplan G.

Infect Immun. 2008 Jul;76(7):3027-36. doi: 10.1128/IAI.01663-07. Epub 2008 Apr 28.

35.

Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis spoligotype family.

Gibson AL, Huard RC, Gey van Pittius NC, Lazzarini LC, Driscoll J, Kurepina N, Zozio T, Sola C, Spindola SM, Kritski AL, Fitzgerald D, Kremer K, Mardassi H, Chitale P, Brinkworth J, Garcia de Viedma D, Gicquel B, Pape JW, van Soolingen D, Kreiswirth BN, Warren RM, van Helden PD, Rastogi N, Suffys PN, Lapa e Silva J, Ho JL.

J Clin Microbiol. 2008 Apr;46(4):1259-67. doi: 10.1128/JCM.02231-07. Epub 2008 Jan 30.

36.

Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil.

Lazzarini LC, Huard RC, Boechat NL, Gomes HM, Oelemann MC, Kurepina N, Shashkina E, Mello FC, Gibson AL, Virginio MJ, Marsico AG, Butler WR, Kreiswirth BN, Suffys PN, Lapa E Silva JR, Ho JL.

J Clin Microbiol. 2007 Dec;45(12):3891-902. Epub 2007 Sep 26.

37.

Insights into the evolutionary history of tubercle bacilli as disclosed by genetic rearrangements within a PE_PGRS duplicated gene pair.

Karboul A, Gey van Pittius NC, Namouchi A, Vincent V, Sola C, Rastogi N, Suffys P, Fabre M, Cataldi A, Huard RC, Kurepina N, Kreiswirth B, Ho JL, Gutierrez MC, Mardassi H.

BMC Evol Biol. 2006 Dec 12;6:107.

38.

Geoinformational mapping of foci of Siberian tick-borne rickettsiosis in Altai Krai.

Kurepina NY, Rotanova IN, Obert AS, Rudakov NV.

Ann N Y Acad Sci. 2006 Oct;1078:185-7.

PMID:
17114706
39.

Molecular epidemiology of tuberculosis: current insights.

Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN.

Clin Microbiol Rev. 2006 Oct;19(4):658-85. Review.

40.

Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D.

J Clin Microbiol. 2006 Dec;44(12):4498-510. Epub 2006 Sep 27.

41.

[Analysis of chromosome deletions of TbDl, RD6 and pks15/1 in clinical strains of Mycobacterium tuberculosis].

Likhoshvaĭ EIu, Kurepina NE, Sinsimer D, Belikov SI, Kreiswirth BN.

Mol Gen Mikrobiol Virusol. 2006;(3):30-5. Russian.

PMID:
16941845
42.

A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophages.

Timm J, Kurepina N, Kreiswirth BN, Post FA, Walther GB, Wainwright HC, Bekker LG, Kaplan G, McKinney JD.

J Infect Dis. 2006 Jun 15;193(12):1703-10. Epub 2006 May 11.

PMID:
16703514
43.

Identifying Mycobacterium tuberculosis complex strain families using spoligotypes.

Vitol I, Driscoll J, Kreiswirth B, Kurepina N, Bennett KP.

Infect Genet Evol. 2006 Nov;6(6):491-504. Epub 2006 May 2.

PMID:
16632413
44.

Genetic analysis of mycobacterium tuberculosis strains isolated in Ural region, Russian Federation, by MIRU-VNTR genotyping.

Kovalev SY, Kamaev EY, Kravchenko MA, Kurepina NE, Skorniakov SN.

Int J Tuberc Lung Dis. 2005 Jul;9(7):746-52.

PMID:
16013769
45.

Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli.

Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, Reed MB, Mathema B, Barry CE 3rd, Kaplan G.

J Infect Dis. 2005 Jul 1;192(1):98-106. Epub 2005 May 26.

PMID:
15942899
46.

Targeted hybridization of IS6110 fingerprints identifies the W-Beijing Mycobacterium tuberculosis strains among clinical isolates.

Kurepina N, Likhoshvay E, Shashkina E, Mathema B, Kremer K, van Soolingen D, Bifani P, Kreiswirth BN.

J Clin Microbiol. 2005 May;43(5):2148-54.

47.

Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis.

Ben Amor Y, Shashkina E, Johnson S, Bifani PJ, Kurepina N, Kreiswirth B, Bhattacharya S, Spencer J, Rendon A, Catanzaro A, Gennaro ML.

Scand J Immunol. 2005 Feb;61(2):139-46. Erratum in: Scand J Immunol. 2005 Mar;61(3):298. Amor, YB [corrected to Ben Amor, Y].

48.

Molecular epidemiology of tuberculosis in Prague and South Moravia, Czech Republic: genetic analysis of Mycobacterium tuberculosis isolates by IS6110-RFLP fingerprinting and spoligotyping.

Kurepina NE, Kreiswirth BN, Shaskina E, Driscoll JR, Polanecký V, Kozáková B, Mezenský L, Kubín M.

Cent Eur J Public Health. 2004 Sep;12(3):141-50.

PMID:
15508413
49.

Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers.

Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Bifani PJ, van Soolingen D.

J Clin Microbiol. 2004 Sep;42(9):4040-9.

50.

Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States.

Milan SJ, Hauge KA, Kurepina NE, Lofy KH, Goldberg SV, Narita M, Nolan CM, McElroy PD, Kreiswirth BN, Cangelosi GA.

J Clin Microbiol. 2004 Mar;42(3):1064-8.

Supplemental Content

Loading ...
Support Center